Delivery Order SPE2DB20D9127-SPE2DB22FPPN1
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,531.40 firm fixed-price delivery order is for the supply of 4,560 units of the injectable oncology medication Oncaspar (pegaspargase) in 5 mL vials. The delivery order is part of a larger single-award Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at...
- This federal contract award, valued at $43,220.28, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,559,233,967 units of the oncology medication Oncaspar (pegaspargase) in 5 mL vials. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $43,220.28, is a firm fixed-price delivery order for the supply of 4,556,239,764 units of the oncology drug Oncaspar (pegaspargase) in 5 ml vials. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $43,220.28 firm fixed-price delivery order is for the supply of 4,556,804,056 units of the oncology medication ONCASPAR (pegaspargase) in 5 mL vials. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, which allows the DLA to issue...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,563,469,460 units of the oncology medication Oncaspar (pegaspargase) in 5 milliliter vials. The $49,531.40 firm fixed-price delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $43,220.28 delivery order is for 4,557 units of the oncology medication Oncaspar (Pegaspargase) 3,750 unit/5 mL vial. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA...
- The Defense Logistics Agency (DLA) awarded a $49,531.40 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,561,926,430 units of the oncology medication Oncaspar in 5 mL vials. This contract is not associated with a set-aside designation. DMS Pharmaceutical Group holds a larger $499,999,999 single-award Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $82,930.72 delivery order is for 3,750 units of the oncology medication ONCASPAR in 5 ML vials. The award is under a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 between DMS Pharmaceutical Group and the DLA, which enables the DLA to issue delivery orders for a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $86,781.56 firm fixed-price contract is for the delivery of 3,750 units of the drug Oncaspar in 5 ML vials. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the DLA to...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $49,531.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 3,750 units of the prescription drug Oncaspar (asparaginase pegylated) in 5 mL vials. This contract is issued under a larger single-award Indefinite Delivery Contract (IDC) valued at $499,999,999, which enables the DLA to place delivery...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB22FPPN1Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $65,086.14 firm fixed-price delivery order covers the provision of 4,558,704,484 units of the injectable chemotherapy medication Oncaspar (pegaspargase) in 5 mL vials. The delivery order falls under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This contract award does not have a set-aside designation. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides a diverse array of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $65.1k | 9/8/22 |